Cell Impact AB (publ) Overview
Get informed when a big investor buys or sells
+ Follow-122.72%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for CI-B.ST is -122.72%. That is below the sector sector average of 11.64%. Investors often review this figure alongside Cell Impact AB (publ)'s historical trend and sector peers before judging valuation or financial health.
Against its sector companies, CI-B.ST currently prints -122.72% for ROE, while the sector average sits near 11.64%. That is roughly 1154.6% below the sector mean. Large gaps often invite a closer look at Cell Impact AB (publ)'s growth, margins, and balance sheet.
Return on Equity shows how effectively Cell Impact AB (publ) converts resources into returns. At -122.72%, CI-B.ST may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting CI-B.ST's ROE (-122.72%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
